J, E., T, T., & J, P. (2016). Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: Role of nilotinib. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Emole, Talabi T, and Pinilla-Ibarz J. Update on the Management of Philadelphia Chromosome Positive Chronic Myelogenous Leukemia: Role of Nilotinib. Dove Medical Press, 2016.
MLA (8th ed.) CitationJ, Emole, et al. Update on the Management of Philadelphia Chromosome Positive Chronic Myelogenous Leukemia: Role of Nilotinib. Dove Medical Press, 2016.
Warning: These citations may not always be 100% accurate.